Fonar

NAQ:FONR · US3444374058

Health Care Equipment & SuppliesSmall

360

Medium confidence — indicative

Value53

Profit price15

Cash yield45

Owner Earnings Yield88

Dividend Yield1

Sales & asset price82

Price/Sales81

EV / Gross Profit68

Price/Book97

Quality61

Returns on capital79

Return on Capital75

Cash Return on Capital81

Return on Equity82

Profit margins52

EBIT Margin83

Gross Profitability20

Cash backing53

Cash Conversion51

Accruals26

Owner Earnings Margin83

Growth40

Sales growth14

Profit growth30

Profit Growth13

Long-Term EPS Growth25

Owner Earnings Growth51

Reinvestment29

Price momentum79

Safety62

Debt load62

Debt serviceability99

Refinancing97

Debt Payback100

Liquidity100

Sentiment40

Analyst ratings—

Expectations trend—

Market mood13

Value Creation8/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Fonar clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeSmall

TypePrivate Company

ExchangeNASDAQCM

Founded1978

Employees38

Websitefonar.com

ISINUS3444374058

Last UpdateApr 2, 2026

Indices

NASDAQ (USA)

Themes

Health DiagnosticsBiomedical EngineeringBiotechnologyHealth CareMedicalMedical Device

Description

FONAR Corporation (FONAR) engages in the designing, manufacturing, selling, and servicing magnetic resonance imaging scanners (MRI or MR scanners), which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other me…

Analysis

Middle-of-the-road

FONAR Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is fair. The owner-earnings multiple stands at 15.6×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is sturdy. The company scores 8/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250

20232026

All-time high

Jan 2023

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Fonar with its peers

Teleflex

NYQ:TFX

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeLarge

Full Stock Analysis →

GE Healthcare

NSQ:GEHC

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeX-Large

Full Stock Analysis →

Hyperfine

NMQ:HYPR

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeSmall

Full Stock Analysis →

IRadimed

NMQ:IRMD

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeSmall

Full Stock Analysis →

Profound Medical

TOR:PRN

CountryCanada

IndustryHealth Care Equipment & Supplies

SizeSmall

Full Stock Analysis →

ClearPoint Neuro

NAQ:CLPT

CountryUSA

IndustryHealth Care Equipment & Supplies

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →